First step to new therapy for chronic bowel disease
Tuesday, July 6, 2010 - 08:56
in Health & Medicine
Scientists associated with VIB (Flanders Institute for Biotechnology) and Ghent University (UGent) have discovered that A20 protein plays an important protective role in diseases associated with chronic bowel inflammation. This makes A20 into a promising therapeutic target for the development of new anti-inflammatory drugs.